Pharma Reviews: 18% of Indian pharma launches to be delayed in US, says Crisil

MUMBAI: Rating agency Crisil has said the woes of Indian generic companies are likely to continue as the regulatory action by the US Food and Drug ...
Read more: 18% of Indian pharma launches to be delayed in US, says Crisil